Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 149
- +5 vs. Q3 2021
- Portfolio value
- $349.4M
- −$87.3M (−20.0%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 613,126 | $37.3M | 10.7% | +86,626+16.5% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 1,020,917 | $17.1M | 4.9% | +1,020,917 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 419,216 | $16.2M | 4.6% | +148,785+55.0% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 191,140 | $16.1M | 4.6% | +98,796+107.0% | Added | History |
| GOSSGossamer Bio, Inc. | COM | 1,166,933 | $13.2M | 3.8% | −185,000−13.7% | Reduced | History |
| SRRASierra Oncology, Inc. | COM NEW | 569,029 | $12.4M | 3.5% | −4,351−0.8% | Reduced | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,750,043 | $11.5M | 3.3% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 737,546 | $9.91M | 2.8% | −145,500−16.5% | Reduced | History |
| ACETAdicet Bio, Inc. | COM | 477,418 | $8.35M | 2.4% | +85,000+21.7% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 75,661 | $8.15M | 2.3% | +50,000+194.8% | Added | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,691,110 | $7.45M | 2.1% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 29,533 | $7.09M | 2.0% | −2,710−8.4% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 295,111 | $7.02M | 2.0% | 00.0% | Unchanged | History |
| MCRBSeres Therapeutics, Inc. | COM | 795,903 | $6.63M | 1.9% | +189,349+31.2% | Added | History |
| PRDSPardes Biosciences, Inc. | COM | 400,000 | $6.55M | 1.9% | +400,000 | New | History |
| INBXInhibrx Biosciences, Inc. | COM | 149,850 | $6.54M | 1.9% | −140,000−48.3% | Reduced | History |
| AYLAOld Ayala, Inc | COM | 669,271 | $5.70M | 1.6% | +130,332+24.2% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 179,138 | $5.60M | 1.6% | −198,300−52.5% | Reduced | History |
| XFORX4 Pharmaceuticals, Inc | COM | 2,264,491 | $5.19M | 1.5% | −275,426−10.8% | Reduced | History |
| CMRXChimerix Inc | COM | 795,410 | $5.11M | 1.5% | −5,898−0.7% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 86,865 | $4.86M | 1.4% | 00.0% | Unchanged | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 164,082 | $4.80M | 1.4% | +164,082 | New | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 196,408 | $4.74M | 1.4% | +185,000+1,621.7% | Added | History |
| SCPHscPharmaceuticals Inc. | COM | 901,362 | $4.53M | 1.3% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 970,398 | $3.68M | 1.1% | −217,500−18.3% | Reduced | History |
| iShares Tr464287556 | ISHARES BIOTECH | 24,022 | $3.67M | 1.0% | +24,022 | New | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 172,521 | $3.29M | 0.9% | 00.0% | Unchanged | History |
| FNCHFinch Therapeutics Group, Inc. | COM | 315,732 | $3.15M | 0.9% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 993,481 | $3.12M | 0.9% | 00.0% | Unchanged | History |
| CLVSClovis Oncology, Inc. | COM | 1,112,669 | $3.02M | 0.9% | 00.0% | Unchanged | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 629,384 | $2.83M | 0.8% | 00.0% | Unchanged | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 544,819 | $2.83M | 0.8% | 00.0% | Unchanged | History |
| RCORRenovacor, Inc. | COM | 342,902 | $2.64M | 0.8% | −100,000−22.6% | Reduced | History |
| MGNXMacrogenics Inc | COM | 156,047 | $2.51M | 0.7% | −32,431−17.2% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 500,642 | $2.30M | 0.7% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 705,082 | $2.26M | 0.6% | −400,000−36.2% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 23,700 | $2.01M | 0.6% | 00.0% | Unchanged | History |
| CLNNClene Inc. | COMMON STOCK | 489,321 | $2.01M | 0.6% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 100,739 | $1.91M | 0.5% | +100,739 | New | History |
| SVRASavara Inc | COM | 1,539,691 | $1.91M | 0.5% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 164,174 | $1.90M | 0.5% | −250,000−60.4% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 279,256 | $1.89M | 0.5% | −200,739−41.8% | Reduced | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 82,335 | $1.88M | 0.5% | +82,335 | New | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 265,264 | $1.83M | 0.5% | −20,000−7.0% | Reduced | History |
| ODTOdonate Therapeutics, Inc. | COM | 1,340,631 | $1.81M | 0.5% | −500,000−27.2% | Reduced | History |
| LYRALyra Therapeutics, Inc. | COM | 394,536 | $1.72M | 0.5% | −8,914−2.2% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 200,000 | $1.70M | 0.5% | +200,000 | New | History |
| MRUSMerus N.V. | COM | 50,907 | $1.62M | 0.5% | 00.0% | Unchanged | History |
| LQDALiquidia Corp | COM NEW | 325,445 | $1.58M | 0.5% | −559,448−63.2% | Reduced | History |
| IFRXInflaRx N.V. | COM | 331,048 | $1.58M | 0.5% | −300,000−47.5% | Reduced | History |
| NTBLNotable Labs, Ltd. | COM | 790,838 | $1.56M | 0.4% | 00.0% | Unchanged | History |
| RNTXRein Therapeutics, Inc. | COM | 2,763,583 | $1.56M | 0.4% | 00.0% | Unchanged | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 344,578 | $1.52M | 0.4% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 175,000 | $1.50M | 0.4% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 74,560 | $1.47M | 0.4% | −25,000−25.1% | Reduced | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 262,237 | $1.35M | 0.4% | +262,237 | New | History |
| MXCTMaxcyte, Inc. | COM | 130,000 | $1.32M | 0.4% | −20,000−13.3% | Reduced | History |
| VSTMVerastem, Inc. | COM | 637,371 | $1.31M | 0.4% | −590,000−48.1% | Reduced | History |
| TAOXTAO Synergies Inc. | COM NEW | 145,629 | $1.24M | 0.4% | −100,000−40.7% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 421,050 | $1.23M | 0.4% | 00.0% | Unchanged | History |
| AVTXAvalo Therapeutics, Inc. | COM | 718,705 | $1.22M | 0.3% | 00.0% | Unchanged | History |
| GRIGRI Bio, Inc. | COM | 198,085 | $1.18M | 0.3% | 00.0% | Unchanged | History |
| SYBXSynlogic, Inc. | COM | 483,818 | $1.17M | 0.3% | −305,000−38.7% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 86,712 | $1.17M | 0.3% | 00.0% | Unchanged | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 439,356 | $1.16M | 0.3% | +439,356 | New | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 482,610 | $1.16M | 0.3% | −274,935−36.3% | Reduced | History |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 289,550 | $1.16M | 0.3% | 00.0% | Unchanged | History |
| QSIQuantum-Si Inc | COM CL A | 144,406 | $1.14M | 0.3% | 00.0% | Unchanged | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 8,400 | $1.13M | 0.3% | +8,400 | New | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 310,110 | $1.08M | 0.3% | 00.0% | Unchanged | History |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 172,309 | $1.07M | 0.3% | 00.0% | Unchanged | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 1,223,067 | $978.0K | 0.3% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 475,693 | $927.0K | 0.3% | −125,000−20.8% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM | 521,155 | $911.0K | 0.3% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 502,627 | $866.0K | 0.2% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 111,292 | $840.0K | 0.2% | 00.0% | Unchanged | History |
| MBIOMustang Bio, Inc. | COM | 506,033 | $840.0K | 0.2% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM | 134,055 | $804.0K | 0.2% | −375,100−73.7% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 150,484 | $801.0K | 0.2% | 00.0% | Unchanged | History |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 209,082 | $779.0K | 0.2% | −101,959−32.8% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 46,519 | $778.0K | 0.2% | −170,000−78.5% | Reduced | History |
| QCLSQ/C Technologies, Inc. | COM | 124,000 | $751.0K | 0.2% | +124,000 | New | History |
| AGTCApplied Genetic Technologies Corp | COM | 390,394 | $742.0K | 0.2% | 00.0% | Unchanged | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 496,756 | $739.0K | 0.2% | 00.0% | Unchanged | – |
| BCLS Acquisition CorpG0904B105 | COM CL A | 73,789 | $728.0K | 0.2% | 00.0% | Unchanged | – |
| TENXTenax Therapeutics, Inc. | COM NEW | 694,195 | $722.0K | 0.2% | +227,934+48.9% | Added | History |
| VTVTvTv Therapeutics Inc. | CL A | 700,000 | $697.0K | 0.2% | +700,000 | New | History |
| KAKineta, Inc. | COM | 228,761 | $678.0K | 0.2% | 00.0% | Unchanged | History |
| HEPAHepion Pharmaceuticals, Inc. | COM | 553,273 | $630.0K | 0.2% | 00.0% | Unchanged | History |
| PBLAPanbela Therapeutics, Inc. | COM | 338,382 | $592.0K | 0.2% | 00.0% | Unchanged | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 948,526 | $584.0K | 0.2% | 00.0% | Unchanged | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 34,565 | $562.0K | 0.2% | 00.0% | Unchanged | History |
| CDAKCodiak BioSciences, Inc. | COM | 49,680 | $554.0K | 0.2% | −70,215−58.6% | Reduced | History |
| CYTOFAltamira Therapeutics Ltd. | SHS | 304,791 | $553.0K | 0.2% | −94,357−23.6% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 9,038 | $528.0K | 0.2% | +9,038 | New | History |
| LRMRLarimar Therapeutics, Inc. | COM | 47,193 | $510.0K | 0.1% | 00.0% | Unchanged | History |
| ASMBAssembly Biosciences, Inc. | COM | 214,861 | $501.0K | 0.1% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 36,576 | $484.0K | 0.1% | −60,000−62.1% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 87,580 | $473.0K | 0.1% | 00.0% | Unchanged | History |
| RLMDRelmada Therapeutics, Inc. | COM | 20,743 | $467.0K | 0.1% | 00.0% | Unchanged | History |
Options (31)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $60.7M | $10.3M |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $17.4M | $22.9M |
| SRPTSarepta Therapeutics, Inc. | COM | – | $36.0M |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $30.2M |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $26.6M |
| BBIOBridgeBio Pharma, Inc. | COM | $15.2M | $1.67M |
| KODKodiak Sciences Inc. | COM | – | $14.2M |
| LONALeonaBio, Inc. | COM | – | $11.2M |
| ZGNXZogenix, Inc. | COM NEW | – | $9.59M |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $9.46M |
| BMRNBiomarin Pharmaceutical Inc | COM | – | $8.84M |
| RETAReata Pharmaceuticals Inc | CL A | $2.64M | $5.27M |
| RCUSArcus Biosciences, Inc. | COM | $5.04M | – |
| PTGXProtagonist Therapeutics, Inc | COM | – | $4.34M |
| IOVAIovance Biotherapeutics, Inc. | COM | $3.74M | – |
| INBXInhibrx Biosciences, Inc. | COM | – | $3.53M |
| ACETAdicet Bio, Inc. | COM | – | $3.50M |
| NKTRNektar Therapeutics | COM | – | $3.38M |
| KZRKezar Life Sciences, Inc. | COM | – | $2.83M |
| ALLKAllakos Inc. | COM | $366.0K | $2.13M |
| GOSSGossamer Bio, Inc. | COM | – | $2.26M |
| ARNAArena Pharmaceuticals Inc | COM NEW | – | $2.07M |
| TGTXTG Therapeutics, Inc. | COM | $1.87M | – |
| CABACabaletta Bio, Inc. | COM | – | $1.60M |
| AVIRAtea Pharmaceuticals, Inc. | COM | – | $1.04M |
| ZLABZai Lab Ltd | ADR | – | $603.0K |
| RFLRafael Holdings, Inc. | COM CL B | $510.0K | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | $8.00K | $291.0K |
| SAGESage Therapeutics, Inc. | COM | – | $192.0K |
| MRTXMirati Therapeutics, Inc. | COM | $191.0K | – |
| ICPTIntercept Pharmaceuticals, Inc. | COM | $18.0K | – |
Sold out since Q3 2021 (22)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 347,545 | $11.5M | 2.6% | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 211,670 | $7.89M | 1.8% | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 229,202 | $6.85M | 1.6% | History |
| BCABBioAtla, Inc. | COM | 196,400 | $5.78M | 1.3% | History |
| ALLKAllakos Inc. | COM | 31,526 | $3.34M | 0.8% | History |
| VINCVincerx Pharma, Inc. | COM NEW | 199,057 | $3.22M | 0.7% | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 27,968 | $3.13M | 0.7% | History |
| TCDATricida, Inc. | COM | 670,771 | $3.11M | 0.7% | History |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 40,961 | $3.06M | 0.7% | – |
| STROSutro Biopharma, Inc. | COM | 134,575 | $2.54M | 0.6% | History |
| INCYIncyte Corp | COM | 32,666 | $2.25M | 0.5% | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 197,173 | $1.95M | 0.4% | History |
| QNCXQuince Therapeutics, Inc. | COM | 20,160 | $1.85M | 0.4% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 53,370 | $1.57M | 0.4% | History |
| STTKShattuck Labs, Inc. | COM | 36,240 | $739.0K | 0.2% | History |
| IMVTImmunovant, Inc. | COM | 83,046 | $722.0K | 0.2% | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 59,422 | $677.0K | 0.2% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 6,496 | $602.0K | 0.1% | History |
| KLDOKaleido Biosciences, Inc. | COM | 100,000 | $546.0K | 0.1% | History |
| INMBInmune Bio, Inc. | COM | 26,632 | $517.0K | 0.1% | History |
| DCTHDelcath Systems, Inc. | COM NEW | 44,857 | $468.0K | 0.1% | History |
| COGTCogent Biosciences, Inc. | COM | 30,727 | $258.0K | 0.1% | History |